BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Szalay F, Hantos MB, Horvath A, Lakatos PL, Folhoffer A, Dunkel K, Hegedus D, Tekes K. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World J Gastroenterol 2004; 10(1): 42-45 [PMID: 14695766 DOI: 10.3748/wjg.v10.i1.42]
URL: https://www.wjgnet.com/1948-5182/full/v10/i1/42.htm
Number Citing Articles
1
David E. Kaminsky, Thomas J. Rogers. Suppression of CCL2/MCP-1 and CCL5/RANTES Expression by Nociceptin in Human MonocytesJournal of Neuroimmune Pharmacology 2008; 3(2): 75 doi: 10.1007/s11481-007-9086-y
2
Kaiyuan Wang, Yu Zheng, Yinli Yang, Jian Wang, Baihui Li, Feng Wei, Hongwei Zhao, Xiubao Ren. Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor PrognosisFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00235
3
Federico Sireci, Francesco Lorusso, Francesco Dispenza, Angelo Immordino, Salvatore Gallina, Pietro Salvago, Francesco Martines, Giuseppe Bonaventura, Maria Laura Uzzo, Giovanni Francesco Spatola. A Prospective Observational Study on the Role of Immunohistochemical Expression of Orphanin in Laryngeal Squamous Cell Carcinoma RecurrenceJournal of Personalized Medicine 2023; 13(8): 1211 doi: 10.3390/jpm13081211
4
Saeed Tariq, Syed M. Nurulain, Kornélia Tekes, Ernest Adeghate. Deciphering intracellular localization and physiological role of nociceptin and nocistatinPeptides 2013; 43: 174 doi: 10.1016/j.peptides.2013.02.010
5
Xiaoqiang Wang, Yiying Tao, Chaojin Zhang, Jie Tian, Weifeng Yu. Expression heterogeneity, tumor immune characteristics and the prognosis effects of OPRL1 in patients with tumors: a pan-cancer study combined with bioinformation analyses and in vitro validationAnesthesiology and Perioperative Science 2024; 2(1) doi: 10.1007/s44254-023-00049-9
6
T.A. Barnes, D.G. Lambert. Editorial III: Nociceptin/orphanin FQ peptide-receptor system: are we any nearer the clinic?British Journal of Anaesthesia 2004; 93(5): 626 doi: 10.1093/bja/aeh226
7
Miklós Krepuska, Péter Sótonyi, Csaba Csobay-Novák, Zoltán Szeberin, István Hartyánszky, Endre Zima, Nóra Szilágyi, Ferenc Horkay, Béla Merkely, György Acsády, Kornélia Tekes. Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases—A pilot studyRegulatory Peptides 2011; 169(1-3): 1 doi: 10.1016/j.regpep.2011.01.007
8
Diego M. Avella, Eric T. Kimchi, Renee N. Donahue, Hephzibah Rani S. Tagaram, Patricia J. McLaughlin, Ian S. Zagon, Kevin F. Staveley-O'Carroll. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancerAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2010; 298(2): R459 doi: 10.1152/ajpregu.00646.2009
9
Emilia Naydenova, Petar Todorov, Rositza Zamfirova. Nociceptin OpioidVitamins & Hormones 2015; 97: 123 doi: 10.1016/bs.vh.2014.11.005
10
Richard J. Bodnar, Gad E. Klein. Endogenous opiates and behavior: 2004Peptides 2005; 26(12): 2629 doi: 10.1016/j.peptides.2005.06.010
11
Aldo Spadaro, Antonino Ajello, Carmelo Luigiano, Carmela Morace, Maria Letizia Resta, Grazia Berlinghieri, Salvatore Campo, Claudio Scisca, Angela Alibrandi, Graziella D’arrigo, Nunziata Alessi, Oscar Ferraù, Maria Antonietta Freni. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2006; 12(29): 4716-4720 doi: 10.3748/wjg.v12.i29.4716
12
Melinda Ligeti, Özge Gündüz, Anna Magyar, Erzsébet Kató, András Z. Rónai, Claudio Vita, Imre Varga, Ferenc Hudecz, Géza Tóth, Anna Borsodi, Sándor Benyhe. Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclidesPeptides 2005; 26(7): 1159 doi: 10.1016/j.peptides.2005.01.018
13
Kate H. Easten, Rachel A. Harry, Wendy M. Purcell, Julie D. McLeod. Nociceptin-induced modulation of human T cell functionPeptides 2009; 30(5): 926 doi: 10.1016/j.peptides.2009.01.021
14
Benito Anton, Phillipe Leff, Joseph J. Meissler, Juan C. Calva, Rodolfo Acevedo, Alberto Salazar, Maura Matus, Anabel Flores, Martin Martinez, Martin W. Adler, John P. Gaughan, Toby K. Eisenstein. Nociceptin/Orphanin FQ Suppresses Adaptive Immune Responses In Vivo and at Picomolar Levels In VitroJournal of Neuroimmune Pharmacology 2010; 5(1): 143 doi: 10.1007/s11481-010-9190-2
15
George Notas, Marilena Kampa, Artemissia-Phoebe Nifli, Kostas Xidakis, Despoina Papasava, Kyriaki Thermos, Elias Kouroumalis, Elias Castanas. The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptorsEuropean Journal of Pharmacology 2007; 555(1): 1 doi: 10.1016/j.ejphar.2006.10.018
16
Tessy Joseph, Tat Leang Lee, Chou Ning, Yuji Nishiuchi, Terutoshi Kimura, Hiroyuki Jikuya, Keli Ou, Yau Chin Chin, Shinro Tachibana. Identification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLCPeptides 2006; 27(1): 122 doi: 10.1016/j.peptides.2005.06.013
17
K.M Standifer, C. Simpson-Durand. Reference Module in Biomedical Sciences2016;  doi: 10.1016/B978-0-12-801238-3.99357-7
18
Lubomir Petrov, Elina Tzvetanova, Almira Pavlova, Albena Alexandrova, Rositsa Zamfirova, Margarita Kirkova, Simeon Todorov. In-vivo effects of nociceptin and its structural analogue [Orn9] nociceptin on the antioxidant status of rat blood and liver after carrageenan-induced paw inflammationOpen Medicine 2010; 5(1): 123 doi: 10.2478/s11536-009-0117-3